Vicks First Defence Micro-gel Nasal Spray

Description - Due to current shortages limit of 2 per customer

• First Defence is a Micro-Gel nasal spray based on plant extracts
• This treatment is the first of its kind to tackle the actual virus rather than soothe the symptoms associated with the common cold
• Although this spray is not a cure for the common cold,if it's taken early enough, first defence can stop a cold developing into a full blown one, and cuts symptoms by up to 40%
• The treatment is not a drug, it's a viscous gel which aims to trap the virus and create an environment is which it cannot flourish
• The compound then increases the snuffles to help wash the cold away

Directions

• Start to use when at risk of catching a cold, or in the early stages before your cold has fully developed. For best results continue to use for 2 days after symptoms subside
• Before first usage, remove the protective cap from the nozzle, hold bottle upright and prime the pump (into a tissue) by depressing firmly several times
• Adults and children (12 years & older) - Without tilting your head, insert the nozzle into your nostril, aiming the nozzle outwards in the direction of your ear. Then fully depress the pump 2 or 3 times with firm even strokes and avoid inhaling deeply
• Repeat for other nostril
• Allow 4 hours between applications, no more than 4 applications in 24 hours
• For best results continue to use for 48 hours after symptoms subside

Caution

• Not suitable for children under 12 years of age
• When, using First Defence it in normal to experience increased nasal discharge and a temporary stinging or smarting sensation. This is a sign that the product is working, is not harmful to heath, and will not last for long
• If the sensation persists stop using the product

See your doctor before using this product if 

• You are pregnant or breast feeding You have nose, ear or throat sensitivities
• You are susceptible to nose bleeds
• After 7 days your cold in still present Symptoms worsen or are accompanied by fever

Trial

Healthy volunteers were dosed with a cold virus, then treated with either Vicks First response, or a placebo. Of those treated with First Response, 57% went on to develop a cold, whereas of those treated with a placebo, 79% developed a cold.
In a second trial, the product was tested against a naturally aquired cold,The volunteers were asked to start their treatment four times a day as soon as they experienced cold symptoms. Those using First Defence recovered in an average of 6.1 days, compared with 7.2 days for those using a placebo and 8.9 days for those taking no treatment.

.